Thu.Aug 11, 2022

article thumbnail

As pharma M&A ramps up, U.S. execs are bullish on more deals

PharmaVoice

What top executives at Merck, Pfizer and more are saying about M&A as they move into the second half of the year.

242
242
article thumbnail

Study to Evaluate Efficacy of Telehealth Cognitive Behavioral Therapy for Migraine

Pharmacy Times

Study will analyze whether cognitive behavioral therapy telehealth can lower headache days and disability as effectively as cognitive behavioral therapy plus a preventive medication for migraine.

149
149
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Despite AbbVie’s Botox prowess, underdog Galderma has leveraged soft skills to succeed in aesthetics

PharmaVoice

Galderma may not have the biggest name in aesthetics, but as the sector grows past pandemic lows, the company is relying on its people to build a loyal customer base.

130
130
article thumbnail

Overcoming Barriers to Adopting Effective Organizational Culture in Pharmacy

Pharmacy Times

Organizational culture is determined by how the organizational leadership responds to a crisis, how they adapt to new demands and how they correct an employee when mistakes happen.

123
123
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pharma Distribution: Carving New Ground

Pharmaceutical Commerce

Pharmaceutical distribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own.

116
116
article thumbnail

Clinical Overview: Lebrikizumab for Atopic Dermatitis

Pharmacy Times

Lebrikizumab is a novel monoclonal antibody that binds with high affinity to the IL-13 protein to prevent the interaction between IL-13R?1 and IL-4R?, which blocks downstream signal activation along the IL-13 pathway.

123
123

More Trending

article thumbnail

Regions On Rise: Life Sciences Across US

Pharmaceutical Commerce

Exploring the competitive and unique offerings in three of the US’s lower-cost economic development regions—and how success in these areas has been boosted by COVID.

105
105
article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

More than 60 percent of all American adults take prescription drugs , amounting to approximately 131 million individuals. These drugs have been rigorously tested by regulatory bodies around the world before they’re made available to ensure they work as labelled, but despite that, adverse events crop up. In 2016, the estimated annual cost of drug-related morbidity and mortality resulting from non-optimised medication therapy was $528.4 billion in the United States alone.

Dosage 98
article thumbnail

Infusion Centers Must Be Proactive to Reduce Risks

Pharmacy Times

There are several key areas of risk that infusion practices are likely to face at some point, and proactively preparing for these events can help ensure a positive outcome.

65
article thumbnail

Increase in dry powder inhalers could lead to decreases in greenhouse gas emissions

Pharmaceutical Technology

Asthma is a chronic respiratory condition that, according to GlobalData’s Epidemiology Database, affects approximately 14% of the UK population, and almost 88 million people in the seven major markets worldwide (US, UK, France, Germany, Italy, Spain, and Japan). Common symptoms include wheezing, shortness of breath, and limited airflow, which can vary in severity.

64
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

AstraZeneca’s Dato-DXd With Merck’s Keytruda Shows Positive Data for NSCLC

Pharmacy Times

The interim analysis of the TROPION-Lung02 trial demonstrate an overall response rate of 37% in individuals who were treated with datopotamab deruxtecan and pembrolizumab.

65
article thumbnail

3rd TIGIT Axis Therapies Summit

pharmaphorum

The 3rd TIGIT Axis Therapies Summit returns to unite large pharma, innovative biotechs and pioneering academics to discuss the full range of next-generation TIGIT axis targeted drug modalities and maximize TIGIT-axis targeting in the solid tumor, blood cancer and non-oncology setting. Covering deciphering the mechanistic intricacies underlying TIGIT axis signaling , defining combination partners that improve efficacy and strengthen TIGIT targeted pipelines , exploring novel drug designs

article thumbnail

Daily OTC Pearl: Mucinex DM

Pharmacy Times

Mucinex DM is an expectorant and cough suppressant.

65
article thumbnail

Improving patient adherence can elevate trial results: Sweetch

Outsourcing Pharma

A leader from the behavioral science specialist shares ways to use precision engagement and other methods to increase patient adherence in clinical studies.

59
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Daily Medication Pearl: Moxifloxacin Hydrochloride (Avelox)

Pharmacy Times

Moxifloxacin hydrochloride (Avelox) is indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria.

65
article thumbnail

Gemini enters business combination deal with Disc Medicine

Pharmaceutical Technology

Gemini Therapeutics has signed a definitive agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical company. To back the merger, Disc raised funds worth $53.5m from a group of healthcare investors led by Access Biotechnology and also include OrbiMed, Atlas Venture and 5AM Ventures among others. The merged company is expected to be named Disc Medicine, which will have corporate headquarters in Watertown, Massachusetts, US.

59
article thumbnail

Pharmacy Times® and Parata Systems Announce the 2022 Next-Generation Pharmacist® Finalists

Pharmacy Times

Ten category winners will be recognized for their achievements in the pharmacy profession at the Next-Generation Pharmacist® of the Year gala held on September 30, 2022, in Kansas City, Mo.

65
article thumbnail

Key blood clotting protein could be ‘warning light’ for COVID-19 cases

Pharma Times

University of Aberdeen team suggest results indicate that protein PAI-1 could be an early indicator of severe COVID-19

55
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Genetic Counselors Insight: Growing Popularity of At Home Testing

InCrowd

With the growing popularity of at-home testing for genetics, we asked Genetic Counselors their thoughts on at-home testing and its efficacy. We first asked – What do you think about patients doing at home testing? For example, Everlywell, LetsGetChecked, 23andMe etc? On a scale of 1 to 7, with 7 being strongly agree, most questions averaged in the middle ground of 3.17-5.75 with the strongest opinions being on accuracy of the tests and the importance of consulting with a healthcare provide

52
article thumbnail

eCare Plans: Helping Patients Get Better

PioneerRx

It is no secret that independent pharmacists are uniquely positioned to impact the health of their neighbors and patients as the most accessible health care.

52
article thumbnail

Spain’s pharma industry IT recruitment activity rises 18.3% in July 2022

Pharmaceutical Technology

Spain’s pharma industry registered an 18.3% rise in IT hiring activity in July 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring increased by 1.22% in July 2022 when compared with June 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 9.33% share in July 2022, recording a decrease of 0.91% over the last three-month average share.

52
article thumbnail

Mobile Inventory App

PioneerRx

Inventory management in your pharmacy system is simplified with PioneerRx’s Mobile Inventory App.

52
article thumbnail

US pharma industry IT recruitment activity drops 5.1% in July 2022

Pharmaceutical Technology

The US’s pharma industry registered a 5.1% drop in IT hiring activity in July 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 4.42% in July 2022 when compared with June 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.92% share in July 2022, recording an increase of 0.06% over the last three-month average share.

52
article thumbnail

Compound Billing

PioneerRx

PioneerRx’s pharmacy software system makes billing for compounds easier and thorough.

article thumbnail

AstraZeneca’s IT hiring activity rises 8.9% in July 2022

Pharmaceutical Technology

UK-based company AstraZeneca’s IT hiring rose 8.9% in July 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 8.89% in July 2022 when compared with June 2022. IT jobs claimed an 8.1% share in the company’s total hiring activity in July 2022, and recorded a 0.25% decline over the last three-month average share.

52
article thumbnail

Synchronization Calendar

PioneerRx

PioneerRx’s pharmacy software system makes digital medication synchronization possible.

52
article thumbnail

Bayer’s IT hiring activity declines 6.6% in July 2022

Pharmaceutical Technology

Germany-based company Bayer’s IT hiring declined 6.6% in July 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 5.98% in July 2022 when compared with June 2022. IT jobs claimed a 6.13% share in the company’s total hiring activity in July 2022, and recorded a 0.12% growth over the last three-month average share.

52
article thumbnail

The Road to Ownership: A Pharmacist’s Journey

PioneerRx

Entrepreneurship.

52
article thumbnail

Eurofins Scientific’s IT hiring activity declines 1.4% in July 2022

Pharmaceutical Technology

Luxembourg-based company Eurofins Scientific’s IT hiring declined 1.4% in July 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 0.58% in July 2022 when compared with June 2022. IT jobs claimed a 5.85% share in the company’s total hiring activity in July 2022, and recorded a 0.51% decline over the last three-month average share.

52
article thumbnail

Data Conversion and Verification

PioneerRx

Pharmacy software conversion is notorious for being a challenging, stressful process; not so with PioneerRx.

52
article thumbnail

Johnson & Johnson’s IT hiring activity rises 11.0% in July 2022

Pharmaceutical Technology

US-based company Johnson & Johnson’s IT hiring rose 11.0% in July 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 14.48% in July 2022 when compared with June 2022. IT jobs claimed a 4.2% share in the company’s total hiring activity in July 2022, and recorded a 0.21% growth over the last three-month average share.

52
article thumbnail

Mike Matovich: Revisited

PioneerRx

When we first met Mike two years ago, he was exploring creative solutions to combat profit losses at Stillwater Family Pharmacy, the store his family has owned and…

52
article thumbnail

Takeda Pharmaceutical’s IT hiring activity rises 20.1% in July 2022

Pharmaceutical Technology

Japan-based company Takeda Pharmaceutical’s IT hiring rose 20.1% in July 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 10.53% in July 2022 when compared with June 2022. IT jobs claimed a 4.84% share in the company’s total hiring activity in July 2022, and recorded a 0.16% decline over the last three-month average share.

52